Epitomee develops paradigm-shifting ingestible
devices that deploy targeted therapies along the GI tract
devices that deploy targeted therapies along the GI tract
Designed with anatomy in mind
A platform technology with various applications
Engineered for comfortable and effective use
The function, duration, and specific location of Epitomee’s therapies can be adapted and controlled, enabling mechano-sensory stimulation, targeted drug delivery and absorption management.
Self-ingested
Packed in a swallowable
standard size capsule
standard size capsule
Targeted deployment
Controlled activation in
specific regions along the stomach,
duodenum, and small intestine
specific regions along the stomach,
duodenum, and small intestine
Transient activity
Set duration of interaction,
followed by dissolvement
and eviction through
natural bowel movements
followed by dissolvement
and eviction through
natural bowel movements
Collaboration
We partner with multinational industry leaders to commercialize new applications
that fit their strategic needs. Together, we seek to advance innovative therapies
that significantly improve people’s lives.
that fit their strategic needs. Together, we seek to advance innovative therapies
that significantly improve people’s lives.
